InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentation at the 23rd Annual Needham Virtual Healthcare Conference, which is being held April 8-11, 2024.
以色列特拉维夫和迈阿密，2024年4月3日（环球新闻专线）——用于预防中风的cGuard栓塞预防支架系统（EPS）开发商InspireMD, Inc.（纳斯达克股票代码：NSPR）今天宣布，首席执行官马文·斯洛斯曼将在2024年4月8日至11日举行的第23届尼德姆年度虚拟医疗大会上发表公司最新情况演讲。
Presentation details:
演示详情：
| Date: | Wednesday, April 10th |
| Time: | 8:00-8:40 AM ET |
| Webcast: | or on the Events section of the company's Investor Relations website at |
| 日期： | 4 月 10 日星期三第四 |
| 时间： | 美国东部时间上午 8:00-8:40 |
| 网络直播： | 或访问公司投资者关系网站的 “活动” 部分，网址为 |
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD's common stock is quoted on the Nasdaq under the ticker symbol NSPR.
关于 InspireMD, Inc.
InspireMD 希望利用其专有的 MicronET 该技术通过提供卓越的急性疗效和持久、无中风的长期疗效，使其产品成为颈动脉支架植入的行业标准。InspireMD的普通股在纳斯达克上市，股票代码为NSPR。
We routinely post information that may be important to investors on our website. For more information, please visit .
我们经常在我们的网站上发布可能对投资者很重要的信息。欲了解更多信息，请访问。
Investor Contacts:
投资者联系人：
Craig Shore
Chief Financial Officer
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com
克雷格肖尔
首席财务官
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com
Chuck Padala, Managing Director
LifeSci Advisors
646-627-8390
chuck@lifesciadvisors.com
investor-relations@inspiremd.com
查克·帕达拉，董事总经理
生命科学顾问
646-627-8390
chuck@lifesciadvisors.com
investor-relations@inspiremd.com